[Contribution to the antigenic study of influenza viruses in animals. II.–Antibodies, antineuraminidase in horse: conditions of apparition and importance (author’s transl)].

The research article essentially discusses how antibodies against neuraminidase – an enzyme that helps in the release of influenza virus from infected cells – appear and function in horses, particularly in relation to two subtypes of horse influenza virus. This information helps in assessing the effectiveness of equine influenza vaccines.

Specific Titration of Antibodies

• The study begins by discussing how to accurately measure the level of antibodies against neuraminidase for two specific types of horse influenza virus.
• It outlines the use of two different antigens to conduct this measurement – the H72Neq 1 recombination agent for anti-Neq1 antibodies, and the A/Duck/Ukraine/63 strain for anti-Neq2 antibodies.

Immunity Response to Neuraminidase

• The immunity response to neuraminidase is found to occur after the horse has contracted the natural disease.
• The authors study this response in two areas or “foci”, each affected by a different subtype of the horse influenza virus – one by the A equi I subtype (specifically the Loire 73 strain), and the other by the A equi 2 subtype (the SHN 73 strain).
• The rise of antibodies against neuraminidase is found to be largely similar to the timeline observed for antihemagglutinin antibodies, which also play a key role in the body’s immune response to influenza virus.

Implications of Neuraminidase Immunity for Vaccination

• Vaccination is discovered to also induce an immune response to neuraminidase.
• The intensity of this immune response provides useful information for understanding and determining the efficacy of vaccines against equine influenza.
• This might help to improve current vaccination strategies and enhance the protection offered to horses against influenza.